Results for: supplement quality

NY puberty blocker article

What the New York Times gets wrong about puberty blockers for transgender youth

The New York Times recently published an article expressing grave concern about the use of puberty blockers to treat gender dysphoria in transgender adolescents. Unfortunately, the reporting ignored evidence and important context to weave a narrative portraying puberty blockers as far more risky than they actually are.

, / December 4, 2022

The Aseem Malhotra lecture isn’t what you think it is

In November 2022, Dr. Aseem Malhotra gave a lecture that was more about advancing a narrative than explaining the science.

/ December 3, 2022
Acupuncture

ASCO endorses “integrative oncology” quackery for cancer pain

Last week, the American Society of Clinical Oncology and the Society for Integrative Oncology published guidelines for treating cancer pain. These guidelines endorsed quackery like reflexology and acupuncture. The infiltration of quackademic medicine continues apace in oncology.

/ November 21, 2022

Aromatase inhibitors and acupuncture in breast cancer: Spinning a negative study, four years later

Four years ago, I wrote about an essentially negative study looking at whether acupuncture could alleviate joint pain caused by aromatase inhibitors, a common treatment for estrogen-sensitive breast cancer. The study's back, and it doesn't look any more positive.

/ November 14, 2022

The Plant Paradox: Steven Gundry’s War on Lectins

Most of what Steven Gundry says in his book The Plant Paradox is demonstrably wrong. There is no science-based reason to avoid lectins.

/ October 25, 2022

Study of Multivitamin Use and Memory

Routine multivitamins are likely not the best strategy for cognitive effects.

/ September 21, 2022
SARS-CoV-2

Peer review fail: Vaccine publishes antivax propaganda disguised as “reanalyses” of Pfizer and Moderna COVID-19 vaccine clinical trial data

In order portray COVID-19 vaccines as dangerous, Peter Doshi has now managed to get poorly designed and performed "reanalyses" of the clinical trial data used by the FDA to grant emergency use approval of the Pfizer and Moderna vaccines published in two reputable journals, The BMJ and Vaccine? What happened?

/ September 5, 2022

Zinc for the prevention or treatment of respiratory tract infections: A new systematic review

A new systematic review examines the evidence for zinc to prevent or treat respiratory tract infections.

/ August 18, 2022

Zeno’s Paradox

An elderly German experiments with a new form of acupuncture. Time says acupuncture is entering the mainstream. Acupuncture has been trying to enter for decades. Still not close.

/ July 28, 2022
Fall Armyworm Moth

Novavax: It’s the vaccine that scares antivaxxers, not moth DNA or any ingredient in any vaccine

The Novavax COVID-19 vaccine was recently granted emergency use approval by the FDA. Company executives and some public health officials have expressed hope that this recombinant protein-based vaccine will be more palatable to the vaccine-hesitant than existing vaccines using new (and therefore scarier) mRNA and adenovirus platforms. The reaction to the use of moth cells to produce the Novavax vaccine shows that...

/ July 25, 2022